Abstract: The invention comprises methods for treating and/or preventing cardiovascular, cholesterol, and lipid related disorders, including atherosclerosis, through co-administration of therapeutically effective amounts of RVX-208 or a pharmaceutically acceptable salt thereof and rosuvastatin or a pharmaceutically acceptable salt thereof. The invention further provides compositions comprising a therapeutically effective amount of RVX-208 or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of rosuvastatin or a pharmaceutically acceptable salt thereof.

Abstract: A method of determining whether to generate a video refresh request includes receiving a packet and performing at least one of determining whether the received packet contains an error and determining whether a packet prior to the received packet was lost. Responsive to a determination that the received packet contains an error, an error index is increased. Responsive to a determination that a packet prior to the received packet has been lost, the error index is increased. Responsive to a determination that the received packet does not contain an error and that a packet prior to the received packet has not been lost, the error index is decreased.

Abstract: A method of determining whether to generate a video refresh request includes receiving a packet and performing at least one of determining whether the received packet contains an error and determining whether a packet prior to the received packet was lost. Responsive to a determination that the received packet contains an error, an error index is increased. Responsive to a determination that a packet prior to the received packet has been lost, the error index is increased. Responsive to a determination that the received packet does not contain an error and that a packet prior to the received packet has not been lost, the error index is decreased. This Abstract is provided to comply with rules requiring an Abstract that allows a searcher or other reader to quickly ascertain subject matter of the technical disclosure. This Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).

Abstract: A method for treatment of a patient for obtaining an increased concentration of a factor selected from the group consisting of growth hormone, insulin-like growth factor (IGF-I) and IGFBP-3 in cerebrospinal fluid by administration of growth hormone or analogues thereof to a patient in need of said treatment.